BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20118200)

  • 1. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways.
    Kim S; Kang HY; Nam EH; Choi MS; Zhao XF; Hong CS; Lee JW; Lee JH; Park YK
    Carcinogenesis; 2010 Apr; 31(4):597-606. PubMed ID: 20118200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition.
    Jung H; Lee KP; Park SJ; Park JH; Jang YS; Choi SY; Jung JG; Jo K; Park DY; Yoon JH; Park JH; Lim DS; Hong GR; Choi C; Park YK; Lee JW; Hong HJ; Kim S; Park YW
    Oncogene; 2008 Apr; 27(18):2635-47. PubMed ID: 17968309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TMPRSS4 during cancer progression.
    Choi SY; Shin HC; Kim SY; Park YW
    Drug News Perspect; 2008 Oct; 21(8):417-23. PubMed ID: 19034347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZEB2 upregulates integrin α5 expression through cooperation with Sp1 to induce invasion during epithelial-mesenchymal transition of human cancer cells.
    Nam EH; Lee Y; Park YK; Lee JW; Kim S
    Carcinogenesis; 2012 Mar; 33(3):563-71. PubMed ID: 22227038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling.
    Kong B; Michalski CW; Hong X; Valkovskaya N; Rieder S; Abiatari I; Streit S; Erkan M; Esposito I; Friess H; Kleeff J
    Oncogene; 2010 Sep; 29(37):5146-58. PubMed ID: 20581862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TMPRSS4 upregulates uPA gene expression through JNK signaling activation to induce cancer cell invasion.
    Min HJ; Lee Y; Zhao XF; Park YK; Lee MK; Lee JW; Kim S
    Cell Signal; 2014 Feb; 26(2):398-408. PubMed ID: 23978400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.
    Larue L; Bellacosa A
    Oncogene; 2005 Nov; 24(50):7443-54. PubMed ID: 16288291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
    Bagnato A; Rosanò L
    Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFbeta-induced EMT requires focal adhesion kinase (FAK) signaling.
    Cicchini C; Laudadio I; Citarella F; Corazzari M; Steindler C; Conigliaro A; Fantoni A; Amicone L; Tripodi M
    Exp Cell Res; 2008 Jan; 314(1):143-52. PubMed ID: 17949712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases.
    Cheng H; Fukushima T; Takahashi N; Tanaka H; Kataoka H
    Cancer Res; 2009 Mar; 69(5):1828-35. PubMed ID: 19223533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKCdelta and cofilin activation affects peripheral actin reorganization and cell-cell contact in cells expressing integrin alpha5 but not its tailless mutant.
    Oh MA; Kang ES; Lee SA; Lee EO; Kim YB; Kim SH; Lee JW
    J Cell Sci; 2007 Aug; 120(Pt 15):2717-30. PubMed ID: 17646675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells.
    Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH
    Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha regulates inflammatory and mesenchymal responses via mitogen-activated protein kinase kinase, p38, and nuclear factor kappaB in human endometriotic epithelial cells.
    Grund EM; Kagan D; Tran CA; Zeitvogel A; Starzinski-Powitz A; Nataraja S; Palmer SS
    Mol Pharmacol; 2008 May; 73(5):1394-404. PubMed ID: 18252806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The integrin alpha5beta1 regulates alphavbeta3-mediated extracellular signal-regulated kinase activation.
    Ly DP; Corbett SA
    J Surg Res; 2005 Feb; 123(2):200-5. PubMed ID: 15680379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 overexpression induces a partial epithelial to mesenchymal transition and promotes squamous carcinoma cell invasion and metastasis.
    Zuo J; Ishikawa T; Boutros S; Xiao Z; Humtsoe JO; Kramer RH
    Mol Cancer Res; 2010 Feb; 8(2):170-82. PubMed ID: 20145039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB2-Sp1 cooperation induces invasion by upregulating cadherin-11 and integrin α5 expression.
    Nam EH; Lee Y; Zhao XF; Park YK; Lee JW; Kim S
    Carcinogenesis; 2014 Feb; 35(2):302-14. PubMed ID: 24130169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoids increase alpha5 integrin expression and adhesion of synovial fibroblasts but inhibit ERK signaling, migration, and cartilage invasion.
    Lowin T; Straub RH; Neumann E; Bosserhoff A; Vogel C; Moissl C; Anders S; Müller-Ladner U; Schedel J
    Arthritis Rheum; 2009 Dec; 60(12):3623-32. PubMed ID: 19950288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling pathways involved in collagen-induced disruption of the E-cadherin complex during epithelial-mesenchymal transition.
    Imamichi Y; Menke A
    Cells Tissues Organs; 2007; 185(1-3):180-90. PubMed ID: 17587824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.